Biomarkers · Chemical
A plain-language description with its source has not been added for this biomarker yet. What the laboratories say about the tests that measure it is below.
What the laboratory says this test is for
This panel evaluates for the most common hereditary and acquired venous thrombophilia risk factors.
Quest Diagnostics test directory, test code 19656
Quest Diagnostics test directory, test code 19672
Quest Diagnostics test directory, test code 19671
What the laboratory says this test is for
The antiphospholipid antibody syndrome (APS) is a clinical-pathologic correlation that includes a clinical event (e.g. arterial or venous thrombosis, pregnancy morbidity) and persistent positive antiphospholipid antibodies (IgM, IgG Cardiolipin or b2GPI antibodies greater than the 99th percentile; or a lupus anticoagulant). International consensus guidelines for APS suggest waiting at least 12 weeks before retesting to confirm antibody persistence. The Systemic Lupus International Collaborating Clinics immunological classification criteria for systemic lupus erythematosus (SLE) include testing for isotype IgA, which has yet to be incorporated into APS criteria. Low level antiphospholipid antibodies may sometimes be detected in the setting of infection, drug therapy or aging.Note: Target-specific anticoagulant therapy (anti-Xa medications, direct thrombin inhibitors) may cause false positive results for Lupus anticoagulant testing but do not impact the Cardiolipin, B2GPI and Phosphatidylserine-Prothrombin antibody testing.
Quest Diagnostics test directory, test code 14890
What the laboratory says this test is for
This panel evaluates for the most common hereditary and acquired venous thrombophilia risk factors except for Protein C and S.
Quest Diagnostics test directory, test code 19655
Quest Diagnostics test directory, test code 19654
What the laboratory says this test is for
This panel can be helpful in the diagnosis of systemic rheumatic disorders and other autoimmune diseases. Although the test for antinuclear antibodies (ANA) is strongly associated with systemic lupus erythematosus (SLE), the laboratory evaluation for individuals with clinical suspicion of a variety of autoimmune diseases often begins with an ANA screen. This panel simultaneously tests for ANA (using immunofluorescence) as well as the important specific autoantibodies associated with a positive ANA. It also includes testing for complement proteins, rheumatoid arthritis, Sjogren's syndrome, systemic sclerosis, polymyositis, anti-phospholipid antibody syndrome, and autoimmune thyroid disease.
Quest Diagnostics test directory, test code 36378
What the laboratory says this test is for
This assay may be useful in supporting or ruling out a diagnosis of antiphospholipid syndrome.
Quest Diagnostics test directory, test code 19872
What the laboratory says this test is for
This profile examines the most common hereditary and acquired thrombophilia risk factors associated with recurrent miscarriage or stillbirth.
Quest Diagnostics test directory, test code 11469
What the laboratory says this test is for
This panel evaluates for the most common hereditary and acquired venous thrombophilia risk factors.
Quest Diagnostics test directory, test code 11475
What the laboratory says this test is for
This panel evaluates for the most common hereditary and acquired venous thrombophilia risk factors except for Protein C and S.
Quest Diagnostics test directory, test code 11472
Everything above is drawn from the named sources and shown as they published it. Reference ranges belong to the laboratory that issued them and the population it named; they are not a universal normal. This page describes the biomarker in general and does not interpret anyone's result. For your own numbers, talk to a clinician, or use Aumnivida, which reads the same graph next to your records.
Found an error? Write to hello@biomarkerlens.com with the page link and the source that contradicts it.